Intrathecal Pumps Market Size, Growth, Trends | Report 2022-2030
The global intrathecal pumps market was surpassed at USD 325.74 million in 2021 and is expected to hit around USD 513.55 million by 2030, growing at a CAGR of 5.19% from 2022 to 2030
Report Highlights
The increasing demand for advanced intrathecal pumps for rapid delivery of medications into the spinal cord for faster pain relief is expected to boost the industry's growth during the forecast period.The advantages associated with intrathecal pumps are anticipated to augment the industry growth. Medications, such as opioids, when given through an intrathecal pain pump give superior pain relief as well as reduce side effects. Also, a small amount of medication is required in pain pumps as compared to the amount of medication taken in pill form, thereby increasing its preference among individuals.
The drug delivery therapy systems offer numerous benefits, such as effective pain relief, high patient satisfaction, reduced side effects compared to oral medication, and reduced use of pain medication. In addition, this treatment is effective and safe when used as directed and can be customized by varying the dosage as per need. Hence, rising demand for targeted drug delivery systems is expected to boost industry growth.The complications associated with the intrathecal catheter are creating hindrance in the industry growth. Occlusion, lacerations, and disconnection of the catheter cause a sudden cessation of intrathecal drug administration due to intrathecal catheter failure. Also, the majority of drug delivery device-related adverse events occurdue to the failure of the intrathecal catheter.
Scope of The Report
| Report Coverage | Details |
| Market Size in 2021 | USD 325.74 million |
| Revenue Forecast by 2030 | USD 513.55 million |
| Growth rate from 2022 to 2030 | CAGR of 5.19% |
| Base Year | 2021 |
| Forecast Period | 2022 to 2030 |
| Segmentation | Type, application, Region |
| Companies Covered | Medtronic plc; Flowonix; Medallion Therapeutics; Arrow International, Inc.; Tricumed GmbH; Codman & Shurtleff |
Type Insights
The morphine segment accounted for the largest revenue share of more than 31.04% in 2021. Morphine is considered the gold standard in intrathecal drug administration owing to its strong receptor affinity, stability, and extensive user experience of the drug. Additionally, morphine has received approval for long-term intrathecal pain treatment by the U.S. FDA. Furthermore, long-term intrathecal morphine has fewer side effects as compared to systemic opioids, expecting to spur the growth of this segment. Bupivacaine is expected to grow at a healthy CAGR of 6.8% over the forecast period. Bupivacaine is considered an excellent adjunct medication in intrathecal therapy.
Several studies have revealed that bupivacaine synergistically improves the effect of the intrathecal opioids when used in combination, significantly contributing to its growing market share. Bupivacaine allows some patients to reduce their oral opioid usage, as well as minimizes dose escalations of intrathecal opioids. Thus, several advantages associated with bupivacaine are anticipated to secure the segment growth. The baclofen type segment is expected to experience a substantial growth rate during the forecast period. Intrathecal baclofen is useful in treating spasticity and pain as well as multiple types of central pain including SCI, post-stroke, and musculoskeletal pain. Thus, the rising prevalence of pain and spasticity is expected to contribute tothe segment growth.
Application Insights
On the basis of applications, the global industry has been further bifurcated into pain and spasticity. The pain application segment dominated the industry and accounted for the largest share of more than 70.43% of the global revenue in 2021. The rising prevalence of chronic and acute disorders, such as chronic pain cancer, and other pain-causing ailments, such as failed back surgery syndrome, is one of the key factors enhancing the segment growth. Hence, intrathecal pumps are best suited for individuals suffering from pain-associated disorders. The spasticity segment is expected to witness a significant growth rate from 2022 to 2030.
Several market players are focusing on developing products for the treatment of spasticity. For instance, Medtronic’s Intrathecal Baclofen Therapy (ITB) is a treatment that uses Lioresal Intrathecal (baclofen) to be distributed into the fluid around an individual’s spinal cord to manage severe spasticity. In addition, rising cases of stroke across the world are one of the major factors contributing to the segment growth. For instance, as per a report published by the American College of Cardiology Foundation in 2019, in every 40 seconds, on average, an American suffers from a stroke and around 795,000 Americans have recurrent & new strokes annually.
Regional Insights
North America region held over 40.67% largest market share in 2021. The availability of well-developed primary, secondary, and tertiary care hospitals supported the market growth in North American region. Moreover, strong reimbursement network, favorable government funding, are major factors predicted to foster market growth. The rising collective efforts by key market companies to improve their product portfolio and ensure high-quality standards are expected to surge the demand for intrathecal pumps across this region.
Asia Pacific is expected to grow at the fastest CAGR of 7.2% during the forecast period. The presence of a large patient pool in Asia Pacific is expected to boost the product demand. An increasing number of pain care centers in China, Singapore, Japan, and India is expected to boost the adoption of intrathecal pumps. For instance, Singapore Pain Care Center (SPCC) is a pain management center in Southeast Asia that provides an alternative to open surgery. The high prevalence of pain-related disorders, increasing R&D expenditure, and the growing number of pain care centers in the U.S. & Canada contributed considerably to the region’s growth. The prevalence of cancer in the U.S. continues to rise at a rapid pace, creating an increased demand for effective and advanced intrathecal pumps.
Key Players
Market Segmentation
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Intrathecal Pumps Market
5.1. COVID-19 Landscape: Intrathecal Pumps Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Intrathecal Pumps Market, By Type
8.1. Intrathecal Pumps Market, by Type, 2022-2030
8.1.1. Baclofen
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Bupivacaine
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Clonidine
8.1.3.1. Market Revenue and Forecast (2017-2030)
8.1.4. Morphine
8.1.4.1. Market Revenue and Forecast (2017-2030)
8.1.5. Ziconotide
8.1.5.1. Market Revenue and Forecast (2017-2030)
8.1.6. Others
8.1.6.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Intrathecal Pumps Market, By Application
9.1. Intrathecal Pumps Market, by Application, 2022-2030
9.1.1. Spasticity
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Pain
9.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Intrathecal Pumps Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, by Type (2017-2030)
10.1.2. Market Revenue and Forecast, by Application (2017-2030)
10.1.3. U.S.
10.1.3.1. Market Revenue and Forecast, by Type (2017-2030)
10.1.3.2. Market Revenue and Forecast, by Application (2017-2030)
10.1.4. Rest of North America
10.1.4.1. Market Revenue and Forecast, by Type (2017-2030)
10.1.4.2. Market Revenue and Forecast, by Application (2017-2030)
10.2. Europe
10.2.1. Market Revenue and Forecast, by Type (2017-2030)
10.2.2. Market Revenue and Forecast, by Application (2017-2030)
10.2.3. UK
10.2.3.1. Market Revenue and Forecast, by Type (2017-2030)
10.2.3.2. Market Revenue and Forecast, by Application (2017-2030)
10.2.4. Germany
10.2.4.1. Market Revenue and Forecast, by Type (2017-2030)
10.2.4.2. Market Revenue and Forecast, by Application (2017-2030)
10.2.5. France
10.2.5.1. Market Revenue and Forecast, by Type (2017-2030)
10.2.5.2. Market Revenue and Forecast, by Application (2017-2030)
10.2.6. Rest of Europe
10.2.6.1. Market Revenue and Forecast, by Type (2017-2030)
10.2.6.2. Market Revenue and Forecast, by Application (2017-2030)
10.3. APAC
10.3.1. Market Revenue and Forecast, by Type (2017-2030)
10.3.2. Market Revenue and Forecast, by Application (2017-2030)
10.3.3. India
10.3.3.1. Market Revenue and Forecast, by Type (2017-2030)
10.3.3.2. Market Revenue and Forecast, by Application (2017-2030)
10.3.4. China
10.3.4.1. Market Revenue and Forecast, by Type (2017-2030)
10.3.4.2. Market Revenue and Forecast, by Application (2017-2030)
10.3.5. Japan
10.3.5.1. Market Revenue and Forecast, by Type (2017-2030)
10.3.5.2. Market Revenue and Forecast, by Application (2017-2030)
10.3.6. Rest of APAC
10.3.6.1. Market Revenue and Forecast, by Type (2017-2030)
10.3.6.2. Market Revenue and Forecast, by Application (2017-2030)
10.4. MEA
10.4.1. Market Revenue and Forecast, by Type (2017-2030)
10.4.2. Market Revenue and Forecast, by Application (2017-2030)
10.4.3. GCC
10.4.3.1. Market Revenue and Forecast, by Type (2017-2030)
10.4.3.2. Market Revenue and Forecast, by Application (2017-2030)
10.4.4. North Africa
10.4.4.1. Market Revenue and Forecast, by Type (2017-2030)
10.4.4.2. Market Revenue and Forecast, by Application (2017-2030)
10.4.5. South Africa
10.4.5.1. Market Revenue and Forecast, by Type (2017-2030)
10.4.5.2. Market Revenue and Forecast, by Application (2017-2030)
10.4.6. Rest of MEA
10.4.6.1. Market Revenue and Forecast, by Type (2017-2030)
10.4.6.2. Market Revenue and Forecast, by Application (2017-2030)
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Type (2017-2030)
10.5.2. Market Revenue and Forecast, by Application (2017-2030)
10.5.3. Brazil
10.5.3.1. Market Revenue and Forecast, by Type (2017-2030)
10.5.3.2. Market Revenue and Forecast, by Application (2017-2030)
10.5.4. Rest of LATAM
10.5.4.1. Market Revenue and Forecast, by Type (2017-2030)
10.5.4.2. Market Revenue and Forecast, by Application (2017-2030)
Chapter 11. Company Profiles
11.1. Medtronic plc
11.1.1. Company Overview
11.1.2. Type Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Codman & Shurtleff
11.2.1. Company Overview
11.2.2. Type Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Medallion Therapeutics
11.3.1. Company Overview
11.3.2. Type Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Tricumed GmbH
11.4.1. Company Overview
11.4.2. Type Offerings
11.4.3. Financial Performance
11.4.4. LTE Scientific
11.5. Arrow International Inc.
11.5.1. Company Overview
11.5.2. Type Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
13.2. Glossary of Terms
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers